Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Rational drug selection and new therapeutic tendering facilitated by steps end over with potential saving: the case of SSRIs

  • At: 2009 FIP Congress in Istanbul (Turkey)
  • Type: Presentations + Posters
  • By: AL AHDAB, Ola (Clinical and Practice Research Group, School of Pharmacy, Queen’s University, Belfast, United Kingdom)
  • Co-author(s): Crealey, Grainne (Clinical Research Support Centre, Royal Group of Hospitals Trust, Belfast, United Kingdom)
    Scott, Michael (Northern Health and Social Care Trust, Antrim, Belfast, United Kingdom)
    Mairs, Jill (Regional Pharmaceutical Procurement Unit Northern Health and Social Care Trust, Belfast, United Kingdom)
    Cooper, Steeve (Department of Mental Health, Queen's University, Belfast, United Kingdom)
    Kelly, Chris (Department of Mental Health, Queen's University, Belfast, United Kingdom)
    Mc Elnay, James (Clinical and Practice Research Group, School of Pharmacy, Queen’s University, Belfast, United Kingdom)
  • Abstract:

    Introduction: Drug formularies are used to protect against high medicine costs, and to provide prescribers with a range of safe and appropriate products with demonstrated cost-effectiveness1. Selection methodologies for formulary inclusion include CURE 2, SOJA 3, and STEPS (Safe Therapeutic and Economic Pharmaceuticals Selection) modified SOJA4.

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses